DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Morgan Stanley Maintains Equal-Weight on TransMedics Group, Lowers Price Target to $16

Morgan Stanley maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and lowers the price target from $22 to $16.

Benzinga · 03/04/2020 13:24

Morgan Stanley maintains TransMedics Group (NASDAQ:TMDX) with a Equal-Weight and lowers the price target from $22 to $16.